Across three different prognosis types, patients with high expression of TIMP1 had much worse prognosis outcomes compared to those with low expression, and ROC analysis confirmed the stability of TIMP1 as a diagnostic molecule for CRC (Figure 5C). The gene discussed is TIMP1; the disease is colorectal carcinoma.